IL-13Rα2 promotes glioblastoma multiforme (GBM) invasiveness and proliferation, as well as acting as a negative prognostic marker in lung cancer and luminal invasive subtype breast cancer [20,23,25]. Here, IL13RA2 is linked to glioblastoma.